ENSG — The Ensign Group Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Key stats#
Data provided bySource: Twelve DataPrice data
- Price
- $186.02
- YTD price return
- +6.79%
- YTD total return
- +6.90%
- Market cap
- 10.9B
- Enterprise value
- 12.8B
- Shares outstanding
- 58.3M
- 52W low
- $141.58
- 52W high
- $218.00
- From 52W high
- -14.67%
- From 52W low
- +31.39%
- 52W range
- 58%$142–$218
- Beta
- 0.69
Volume
- Rel volume
- 0.67×
- 30D volume
- 366.5K
- 30D $ vol
- 65.8M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$18K
- Insider net 1Y
- −$4.1M
Form 4 transactions by trade date, as filed; latest on file 2026-10-16.
Fundamentals
- Sales (ttm)
- 5.7B
- Sales/share
- $97.26
- EPS (ttm)
- $6.72
- Book value/share
- $43.87
- Net margin
- 7.03%
- ROE
- 15.59%
- ROA
- 6.65%
- Debt / equity
- 0.08×
- Current ratio
- 1.20
Growth (CAGR, ttm) · 10Y
- Sales
- +17.51%+16.82%+17.23%+13.48%
- Net income
- +21.62%+17.16%+15.73%+24.32%
- FCF
- -24.31%+145.32%n/an/a
- Shares
- +0.72%+1.10%+1.09%+1.42%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +20.06%+15.66%+14.70%+22.76%
- Sales/share
- +16.67%+15.55%+15.96%+11.90%
- FCF/share
- -25.49%+141.23%n/an/a
- Book value/share
- +19.91%+19.26%+19.88%+17.68%
- Dividend/share
- +4.00%+4.17%+4.36%+4.98%
- Price
- +4.77%+20.09%+17.78%+25.02%
- Total return
- +4.92%+20.30%+18.02%+25.47%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 27.7×
- P/OI (ttm)
- 21.3×
- Fwd P/E
- 21.5×
- P/S (ttm)
- 1.9×
- P/B (mrq)
- 4.2×
- EV/EBITDA (fy)
- 20.3×
- EV/Sales (ttm)
- 2.2×
- Dividend yield (fwd)Div yield
- 0.14%
- Dividend yield (ttm)
- 0.14%
- Dividend/share (fwd)
- $0.26
- Buyback yield (realized, 1y)
- -0.72%
- Shareholder yield (realized, 1y)
- -0.57%
- Buyback yield (cash, ttm)
- 0.44%
- Shareholder yield (cash, ttm)
- 0.58%
Vs own 10Y history
- P/E
- 70th
- P/OI
- 69th
- P/S
- 83rd
- P/B
- 59th
- P/FCF
- 12th
Bar = where today’s multiple sits in ENSG’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
Performance · price returntotal return · as of 2026-11-17#
Data provided bySource: Twelve DataFundamentals#
Operating income
5Y CAGR +13.8%10Y CAGR +16.4%YoY +43.4%EPS (diluted)
5Y CAGR +13.8%10Y CAGR +18.6%YoY +23.9%Free cash flow
5Y CAGR +31.1%10Y CAGR +17.3%YoY +21.2%FY25: operating cash flow $564.3M, capex —
Q3 2026: operating cash flow $240.2M, capex —
Shares (diluted)
5Y +5.5%10Y +12.8%YoY +0.6%Dividend per share
5Y CAGR +4.5%10Y CAGR +5.2%YoY +4.0%About Ensign Group#
Data provided bySource: Twelve DataThe Ensign Group, Inc. is a healthcare services holding company that provides post-acute care through independent operating subsidiaries. The company focuses on skilled nursing, rehabilitation, and senior living services, including physical, occupational, and speech therapy, as well as related healthcare support services. It also operates ancillary businesses such as mobile diagnostics and medical transportation, and it acquires, leases, and owns healthcare real estate tied to the post-acute care continuum. The Ensign Group serves patients and residents across multiple U.S. states through a decentralized operating model, making it a notable participant in skilled care, long-term care, and healthcare property services. Headquartered in San Juan Capistrano, California, and founded in 1999, The Ensign Group plays a significant role in delivering care for aging and medically complex populations.
San Juan Capistrano, CA·46,000 employees·Medical Care Facilities·ensigngroup.net·As of Oct 28, 2026
Recent filings#
- Oct 27Earnings · Earnings release — EPS $1.79 vs $1.75 est. (+2.3%); revenue $1.48B (+14% y/y) 8.6%
- Aug 208-K · The Ensign Group Increases Credit Facility to $800 Million and Extends Maturity
- Jul 27Earnings · Earnings release — EPS $1.72 vs $1.63 est. (+5.5%); revenue $1.44B (+17% y/y) 2.9%
ETFs holding ENSG#
21 of the 193 ETFs ChartRow carries live hold ENSG. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| VBK | Vanguard Small-Cap Growth ETF | 0.3% |
| IJH | iShares Core S&P Mid-Cap ETF | 0.3% |
| MDY | SPDR S&P MidCap 400 ETF Trust | 0.3% |
| VHT | Vanguard Health Care ETF | 0.1% |
| VB | Vanguard Small-Cap ETF | 0.1% |
| VXF | Vanguard Extended Market ETF | 0.1% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.1% |
| IWR | iShares Russell Midcap ETF | 0.1% |
Related Healthcare#
Data provided bySource: Twelve Data| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +12.61% | -1.13% |
| JNJ | Johnson & Johnson | +9.05% | -1.36% |
| ABBV | AbbVie Inc. | +2.59% | -0.59% |
| MRK | Merck & Co. Inc. | -1.77% | -0.75% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -2.93% | -5.42% |
| NVS | Novartis AG | +5.65% | -0.67% |
| TMO | Thermo Fisher Scientific Inc. | -0.47% | -0.66% |
| AMGN | Amgen Inc. | +5.88% | -0.95% |
